KAINOS Laboratories, Inc. (TYO:4556)
Japan
· Delayed Price · Currency is JPY 1,174.00
+39.00 (3.44%)
Apr 24, 2025, 3:30 PM JST
KAINOS Laboratories Revenue
KAINOS Laboratories had revenue of 1.14B JPY in the quarter ending December 31, 2010, with 1.52% growth. This brings the company's revenue in the last twelve months to 4.44B, up 8.49% year-over-year. In the fiscal year ending March 31, 2010, KAINOS Laboratories had annual revenue of 4.22B with 17.25% growth.
Revenue (ttm)
4.44B
Revenue Growth
+8.49%
P/S Ratio
1.18
Revenue / Employee
33.36M
Employees
133
Market Cap
5.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2010 | 4.22B | 620.16M | 17.25% |
| Mar 31, 2009 | 3.59B | -364.89M | -9.21% |
| Mar 31, 2008 | 3.96B | -140.10M | -3.42% |
| Mar 31, 2007 | 4.10B | -489.33M | -10.66% |
| Mar 31, 2006 | 4.59B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Takeda Pharmaceutical Company | 4,579.02B |
| Daiichi Sankyo Company | 1,795.99B |
| HOYA Corporation | 838.60B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,867.63B |
| Shionogi & | 456.87B |